nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CMA1—atopic dermatitis	0.557	1	CbGaD
Boceprevir—CYP3A5—Tacrolimus—atopic dermatitis	0.0321	0.142	CbGbCtD
Boceprevir—CYP3A4—Pimecrolimus—atopic dermatitis	0.021	0.0934	CbGbCtD
Boceprevir—ABCB1—Tacrolimus—atopic dermatitis	0.0209	0.0927	CbGbCtD
Boceprevir—ABCB1—Loratadine—atopic dermatitis	0.0153	0.0678	CbGbCtD
Boceprevir—ABCB1—Methylprednisolone—atopic dermatitis	0.014	0.062	CbGbCtD
Boceprevir—CYP3A5—Hydrocortisone—atopic dermatitis	0.0131	0.058	CbGbCtD
Boceprevir—CYP3A4—Tacrolimus—atopic dermatitis	0.0125	0.0555	CbGbCtD
Boceprevir—CYP3A4—Loratadine—atopic dermatitis	0.00916	0.0406	CbGbCtD
Boceprevir—ABCB1—Betamethasone—atopic dermatitis	0.00909	0.0403	CbGbCtD
Boceprevir—ABCB1—Prednisolone—atopic dermatitis	0.00897	0.0398	CbGbCtD
Boceprevir—ABCB1—Hydrocortisone—atopic dermatitis	0.0085	0.0377	CbGbCtD
Boceprevir—ABCB1—Prednisone—atopic dermatitis	0.00847	0.0376	CbGbCtD
Boceprevir—CYP3A4—Methylprednisolone—atopic dermatitis	0.00838	0.0372	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—atopic dermatitis	0.00812	0.0361	CbGbCtD
Boceprevir—CYP3A4—Triamcinolone—atopic dermatitis	0.00635	0.0282	CbGbCtD
Boceprevir—CYP3A4—Betamethasone—atopic dermatitis	0.00545	0.0242	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—atopic dermatitis	0.00537	0.0238	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—atopic dermatitis	0.00529	0.0235	CbGbCtD
Boceprevir—Telaprevir—CMA1—atopic dermatitis	0.00521	1	CrCbGaD
Boceprevir—CYP3A4—Hydrocortisone—atopic dermatitis	0.00509	0.0226	CbGbCtD
Boceprevir—CYP3A4—Prednisone—atopic dermatitis	0.00507	0.0225	CbGbCtD
Boceprevir—CYP3A4—Dexamethasone—atopic dermatitis	0.00317	0.0141	CbGbCtD
Boceprevir—CTSL—neck—atopic dermatitis	0.00297	0.157	CbGeAlD
Boceprevir—CTSV—skin of body—atopic dermatitis	0.00235	0.125	CbGeAlD
Boceprevir—CMA1—skin of body—atopic dermatitis	0.00224	0.119	CbGeAlD
Boceprevir—CTSS—neck—atopic dermatitis	0.00196	0.104	CbGeAlD
Boceprevir—CTSL—skin of body—atopic dermatitis	0.00192	0.102	CbGeAlD
Boceprevir—CTSV—head—atopic dermatitis	0.00153	0.0813	CbGeAlD
Boceprevir—CTSK—skin of body—atopic dermatitis	0.00145	0.0767	CbGeAlD
Boceprevir—CTSS—skin of body—atopic dermatitis	0.00127	0.0672	CbGeAlD
Boceprevir—CTSL—head—atopic dermatitis	0.00125	0.0664	CbGeAlD
Boceprevir—CTSL—Degradation of the extracellular matrix—CMA1—atopic dermatitis	0.000955	0.0137	CbGpPWpGaD
Boceprevir—CTSV—MHC class II antigen presentation—KIF3A—atopic dermatitis	0.000947	0.0136	CbGpPWpGaD
Boceprevir—CTSL—MHC class II antigen presentation—KIF3A—atopic dermatitis	0.000947	0.0136	CbGpPWpGaD
Boceprevir—CTSK—head—atopic dermatitis	0.000944	0.05	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—KLK7—atopic dermatitis	0.000868	0.0124	CbGpPWpGaD
Boceprevir—CTSS—head—atopic dermatitis	0.000827	0.0439	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—CMA1—atopic dermatitis	0.000791	0.0113	CbGpPWpGaD
Boceprevir—CTSK—MHC class II antigen presentation—KIF3A—atopic dermatitis	0.000785	0.0112	CbGpPWpGaD
Boceprevir—CTSK—Osteoclast Signaling—MAPK8—atopic dermatitis	0.000742	0.0106	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—CMA1—atopic dermatitis	0.000652	0.00933	CbGpPWpGaD
Boceprevir—CTSS—MHC class II antigen presentation—KIF3A—atopic dermatitis	0.000646	0.00925	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CTSE—atopic dermatitis	0.000555	0.00795	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CTSE—atopic dermatitis	0.000555	0.00795	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CTSE—atopic dermatitis	0.00046	0.00659	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—NFKBIA—atopic dermatitis	0.00044	0.0063	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000426	0.0061	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000426	0.0061	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CMA1—atopic dermatitis	0.0004	0.00573	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CMA1—atopic dermatitis	0.0004	0.00573	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CTSE—atopic dermatitis	0.000379	0.00543	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FCER1A—atopic dermatitis	0.000357	0.00512	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FCER1A—atopic dermatitis	0.000357	0.00512	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000353	0.00505	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTSE—atopic dermatitis	0.000337	0.00482	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTSE—atopic dermatitis	0.000337	0.00482	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MS4A2—atopic dermatitis	0.000332	0.00476	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MS4A2—atopic dermatitis	0.000332	0.00476	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CMA1—atopic dermatitis	0.000332	0.00475	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FCER1A—atopic dermatitis	0.000296	0.00424	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—DEFB1—atopic dermatitis	0.000296	0.00424	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—DEFB1—atopic dermatitis	0.000296	0.00424	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000291	0.00416	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTSE—atopic dermatitis	0.000279	0.004	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—MAPK8—atopic dermatitis	0.000276	0.00396	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MS4A2—atopic dermatitis	0.000275	0.00394	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CMA1—atopic dermatitis	0.000273	0.00391	CbGpPWpGaD
Boceprevir—CTSL—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000266	0.0881	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000259	0.0857	CbGdCrCtD
Boceprevir—CTSV—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.00025	0.00358	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.00025	0.00358	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—DEFB1—atopic dermatitis	0.000245	0.00351	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FCER1A—atopic dermatitis	0.000244	0.00349	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTSE—atopic dermatitis	0.00023	0.00329	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—GLB1—atopic dermatitis	0.000229	0.00329	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KIF3A—atopic dermatitis	0.000227	0.00325	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KIF3A—atopic dermatitis	0.000227	0.00325	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MS4A2—atopic dermatitis	0.000227	0.00325	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000226	0.00323	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000226	0.00323	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FCER1A—atopic dermatitis	0.000208	0.00298	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FCER1A—atopic dermatitis	0.000208	0.00298	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.000207	0.00297	CbGpPWpGaD
Boceprevir—CTSL—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000206	0.0683	CbGdCrCtD
Boceprevir—CTSS—Innate Immune System—DEFB1—atopic dermatitis	0.000202	0.00289	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—STAT6—atopic dermatitis	0.000201	0.00288	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—STAT6—atopic dermatitis	0.000201	0.00288	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CARD11—atopic dermatitis	0.000196	0.0028	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CARD11—atopic dermatitis	0.000196	0.0028	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MS4A2—atopic dermatitis	0.000193	0.00277	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MS4A2—atopic dermatitis	0.000193	0.00277	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KIF3A—atopic dermatitis	0.000188	0.0027	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CARD11—atopic dermatitis	0.000188	0.00269	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CARD11—atopic dermatitis	0.000188	0.00269	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000187	0.00268	CbGpPWpGaD
Boceprevir—CTSL—Immune System—DEFB1—atopic dermatitis	0.000172	0.00247	CbGpPWpGaD
Boceprevir—CTSV—Immune System—DEFB1—atopic dermatitis	0.000172	0.00247	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FCER1A—atopic dermatitis	0.000172	0.00247	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.000171	0.00244	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Desonide—atopic dermatitis	0.000169	0.0558	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Desonide—atopic dermatitis	0.000169	0.0558	CbGdCrCtD
Boceprevir—CTSK—Innate Immune System—STAT6—atopic dermatitis	0.000167	0.00239	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CARD11—atopic dermatitis	0.000162	0.00232	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MS4A2—atopic dermatitis	0.00016	0.0023	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000157	0.00225	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000157	0.00225	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CARD11—atopic dermatitis	0.000156	0.00223	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KIF3A—atopic dermatitis	0.000155	0.00222	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000154	0.00221	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CASP1—atopic dermatitis	0.000153	0.00218	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CASP1—atopic dermatitis	0.000153	0.00218	CbGpPWpGaD
Boceprevir—ABCB1—head—atopic dermatitis	0.000146	0.00774	CbGeAlD
Boceprevir—CTSK—Immune System—DEFB1—atopic dermatitis	0.000143	0.00205	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FCER1A—atopic dermatitis	0.000142	0.00203	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR2—atopic dermatitis	0.000138	0.00197	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR2—atopic dermatitis	0.000138	0.00197	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KIF3A—atopic dermatitis	0.000138	0.00197	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KIF3A—atopic dermatitis	0.000138	0.00197	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—STAT6—atopic dermatitis	0.000137	0.00197	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Fluocinonide—atopic dermatitis	0.000135	0.0447	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Fluocinonide—atopic dermatitis	0.000135	0.0447	CbGdCrCtD
Boceprevir—CTSS—Innate Immune System—CARD11—atopic dermatitis	0.000134	0.00191	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MS4A2—atopic dermatitis	0.000132	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000131	0.0434	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000131	0.0434	CbGdCrCtD
Boceprevir—CTSK—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.00013	0.00186	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CARD11—atopic dermatitis	0.000128	0.00184	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CASP1—atopic dermatitis	0.000126	0.00181	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FCER2—atopic dermatitis	0.000125	0.00179	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—atopic dermatitis	0.000125	0.00178	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—atopic dermatitis	0.000125	0.00178	CbGpPWpGaD
Boceprevir—CTSL—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000123	0.0408	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000121	0.0402	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000121	0.0402	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000119	0.0393	CbGdCrCtD
Boceprevir—CTSS—Immune System—DEFB1—atopic dermatitis	0.000118	0.00168	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT6—atopic dermatitis	0.000117	0.00168	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT6—atopic dermatitis	0.000117	0.00168	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL22—atopic dermatitis	0.000116	0.00167	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR2—atopic dermatitis	0.000114	0.00164	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KIF3A—atopic dermatitis	0.000114	0.00164	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CARD11—atopic dermatitis	0.000114	0.00163	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CARD11—atopic dermatitis	0.000114	0.00163	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000109	0.00156	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000107	0.00153	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Mometasone—atopic dermatitis	0.000105	0.0346	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Mometasone—atopic dermatitis	0.000105	0.0346	CbGdCrCtD
Boceprevir—CTSS—Innate Immune System—CASP1—atopic dermatitis	0.000104	0.00149	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL27—atopic dermatitis	0.000104	0.00148	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD79A—atopic dermatitis	0.000103	0.00148	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD8A—atopic dermatitis	0.0001	0.00144	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—atopic dermatitis	0.0001	0.00144	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—atopic dermatitis	0.0001	0.00144	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—atopic dermatitis	0.0001	0.00144	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.93e-05	0.00142	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT6—atopic dermatitis	9.71e-05	0.00139	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CARD11—atopic dermatitis	9.45e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—TLR2—atopic dermatitis	9.41e-05	0.00135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KIF3A—atopic dermatitis	9.41e-05	0.00135	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL13—atopic dermatitis	9.33e-05	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—atopic dermatitis	9.32e-05	0.00133	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL17—atopic dermatitis	9.3e-05	0.00133	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CASP1—atopic dermatitis	8.88e-05	0.00127	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CASP1—atopic dermatitis	8.88e-05	0.00127	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	8.58e-05	0.00123	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—atopic dermatitis	8.5e-05	0.00122	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL5—atopic dermatitis	8.42e-05	0.00121	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL5—atopic dermatitis	8.42e-05	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD8A—atopic dermatitis	8.32e-05	0.00119	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—atopic dermatitis	8.31e-05	0.00119	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KIF3A—atopic dermatitis	8.29e-05	0.00119	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—NFKBIA—atopic dermatitis	8.11e-05	0.00116	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NFKBIA—atopic dermatitis	8.11e-05	0.00116	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR2—atopic dermatitis	8.03e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR2—atopic dermatitis	8.03e-05	0.00115	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT6—atopic dermatitis	8e-05	0.00115	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL5—atopic dermatitis	7.98e-05	0.00114	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NFKBIA—atopic dermatitis	7.78e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NFKBIA—atopic dermatitis	7.78e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CARD11—atopic dermatitis	7.78e-05	0.00111	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—atopic dermatitis	7.55e-05	0.00108	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—atopic dermatitis	7.55e-05	0.00108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL11—atopic dermatitis	7.49e-05	0.00107	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CASP1—atopic dermatitis	7.36e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CASP8—atopic dermatitis	7.31e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CASP8—atopic dermatitis	7.31e-05	0.00105	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT6—atopic dermatitis	7.05e-05	0.00101	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL5—atopic dermatitis	6.98e-05	0.000999	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—atopic dermatitis	6.85e-05	0.000981	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—atopic dermatitis	6.84e-05	0.000979	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NFKBIA—atopic dermatitis	6.72e-05	0.000962	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TLR2—atopic dermatitis	6.66e-05	0.000953	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Hydrocortisone—atopic dermatitis	6.62e-05	0.0219	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Hydrocortisone—atopic dermatitis	6.62e-05	0.0219	CbGdCrCtD
Boceprevir—CTSK—Adaptive Immune System—NFKBIA—atopic dermatitis	6.45e-05	0.000923	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—atopic dermatitis	6.26e-05	0.000896	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Methylprednisolone—atopic dermatitis	6.25e-05	0.0207	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Methylprednisolone—atopic dermatitis	6.25e-05	0.0207	CbGdCrCtD
Boceprevir—CTSL—Immune System—IL18—atopic dermatitis	6.18e-05	0.000885	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL18—atopic dermatitis	6.18e-05	0.000885	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Dexamethasone—atopic dermatitis	6.15e-05	0.0204	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Betamethasone—atopic dermatitis	6.15e-05	0.0204	CbGdCrCtD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.12e-05	0.000876	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCR3—atopic dermatitis	6.11e-05	0.000875	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD8A—atopic dermatitis	6.09e-05	0.000872	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—atopic dermatitis	6.09e-05	0.000872	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CASP1—atopic dermatitis	6.06e-05	0.000868	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CASP8—atopic dermatitis	6.06e-05	0.000867	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Triamcinolone—atopic dermatitis	6.01e-05	0.0199	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—atopic dermatitis	6.01e-05	0.0199	CbGdCrCtD
Boceprevir—CTSL—Innate Immune System—CD4—atopic dermatitis	6e-05	0.00086	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—atopic dermatitis	6e-05	0.00086	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL10—atopic dermatitis	5.84e-05	0.000835	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—atopic dermatitis	5.77e-05	0.000825	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—atopic dermatitis	5.77e-05	0.000825	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL5—atopic dermatitis	5.75e-05	0.000823	CbGpPWpGaD
Boceprevir—CTSL—Betamethasone—Prednisone—atopic dermatitis	5.7e-05	0.0189	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisone—atopic dermatitis	5.7e-05	0.0189	CbGdCrCtD
Boceprevir—ABCB1—Allograft Rejection—IL4—atopic dermatitis	5.68e-05	0.000813	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.58e-05	0.000798	CbGpPWpGaD
Boceprevir—CTSL—Dexamethasone—Prednisolone—atopic dermatitis	5.57e-05	0.0184	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisolone—atopic dermatitis	5.57e-05	0.0184	CbGdCrCtD
Boceprevir—CTSS—Innate Immune System—NFKBIA—atopic dermatitis	5.53e-05	0.000792	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR2—atopic dermatitis	5.48e-05	0.000785	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TAC1—atopic dermatitis	5.45e-05	0.00078	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NPS—atopic dermatitis	5.45e-05	0.00078	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCR3—atopic dermatitis	5.34e-05	0.000765	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NFKBIA—atopic dermatitis	5.31e-05	0.00076	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD79A—atopic dermatitis	5.15e-05	0.000738	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL18—atopic dermatitis	5.12e-05	0.000733	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK8—atopic dermatitis	5.09e-05	0.000728	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAPK8—atopic dermatitis	5.09e-05	0.000728	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL5—atopic dermatitis	5.06e-05	0.000725	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD8A—atopic dermatitis	5.05e-05	0.000722	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CASP8—atopic dermatitis	4.99e-05	0.000714	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—atopic dermatitis	4.98e-05	0.000712	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD4—atopic dermatitis	4.78e-05	0.000684	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NFKBIA—atopic dermatitis	4.72e-05	0.000676	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKBIA—atopic dermatitis	4.72e-05	0.000676	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—atopic dermatitis	4.7e-05	0.000672	CbGpPWpGaD
Boceprevir—Malaise—Methylprednisolone—atopic dermatitis	4.58e-05	0.000378	CcSEcCtD
Boceprevir—Vertigo—Triamcinolone—atopic dermatitis	4.58e-05	0.000378	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.57e-05	0.000378	CcSEcCtD
Boceprevir—Syncope—Triamcinolone—atopic dermatitis	4.57e-05	0.000377	CcSEcCtD
Boceprevir—Vertigo—Methylprednisolone—atopic dermatitis	4.57e-05	0.000377	CcSEcCtD
Boceprevir—Syncope—Methylprednisolone—atopic dermatitis	4.56e-05	0.000376	CcSEcCtD
Boceprevir—Discomfort—Hydrocortisone—atopic dermatitis	4.55e-05	0.000376	CcSEcCtD
Boceprevir—Connective tissue disorder—Prednisone—atopic dermatitis	4.54e-05	0.000375	CcSEcCtD
Boceprevir—Vomiting—Tacrolimus—atopic dermatitis	4.5e-05	0.000372	CcSEcCtD
Boceprevir—Loss of consciousness—Triamcinolone—atopic dermatitis	4.48e-05	0.00037	CcSEcCtD
Boceprevir—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.47e-05	0.000369	CcSEcCtD
Boceprevir—Rash—Tacrolimus—atopic dermatitis	4.46e-05	0.000368	CcSEcCtD
Boceprevir—Dermatitis—Tacrolimus—atopic dermatitis	4.46e-05	0.000368	CcSEcCtD
Boceprevir—Shock—Prednisolone—atopic dermatitis	4.45e-05	0.000367	CcSEcCtD
Boceprevir—Cough—Triamcinolone—atopic dermatitis	4.44e-05	0.000367	CcSEcCtD
Boceprevir—Headache—Tacrolimus—atopic dermatitis	4.43e-05	0.000366	CcSEcCtD
Boceprevir—Tachycardia—Prednisolone—atopic dermatitis	4.41e-05	0.000364	CcSEcCtD
Boceprevir—Hypertension—Triamcinolone—atopic dermatitis	4.4e-05	0.000363	CcSEcCtD
Boceprevir—Hypertension—Methylprednisolone—atopic dermatitis	4.39e-05	0.000362	CcSEcCtD
Boceprevir—Infection—Hydrocortisone—atopic dermatitis	4.39e-05	0.000362	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisolone—atopic dermatitis	4.37e-05	0.000361	CcSEcCtD
Boceprevir—Shock—Hydrocortisone—atopic dermatitis	4.34e-05	0.000359	CcSEcCtD
Boceprevir—Myalgia—Triamcinolone—atopic dermatitis	4.34e-05	0.000358	CcSEcCtD
Boceprevir—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.33e-05	0.000357	CcSEcCtD
Boceprevir—Myalgia—Methylprednisolone—atopic dermatitis	4.33e-05	0.000357	CcSEcCtD
Boceprevir—Arthralgia—Methylprednisolone—atopic dermatitis	4.33e-05	0.000357	CcSEcCtD
Boceprevir—Eye disorder—Prednisone—atopic dermatitis	4.32e-05	0.000357	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCL10—atopic dermatitis	4.32e-05	0.000618	CbGpPWpGaD
Boceprevir—Anxiety—Methylprednisolone—atopic dermatitis	4.31e-05	0.000356	CcSEcCtD
Boceprevir—Tachycardia—Hydrocortisone—atopic dermatitis	4.31e-05	0.000356	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.3e-05	0.000355	CcSEcCtD
Boceprevir—Flushing—Prednisone—atopic dermatitis	4.29e-05	0.000354	CcSEcCtD
Boceprevir—Skin disorder—Hydrocortisone—atopic dermatitis	4.29e-05	0.000354	CcSEcCtD
Boceprevir—Ill-defined disorder—Betamethasone—atopic dermatitis	4.29e-05	0.000354	CcSEcCtD
Boceprevir—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.29e-05	0.000354	CcSEcCtD
Boceprevir—Discomfort—Triamcinolone—atopic dermatitis	4.28e-05	0.000354	CcSEcCtD
Boceprevir—Discomfort—Methylprednisolone—atopic dermatitis	4.27e-05	0.000353	CcSEcCtD
Boceprevir—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.27e-05	0.000352	CcSEcCtD
Boceprevir—CTSV—Immune System—CASP8—atopic dermatitis	4.26e-05	0.00061	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CASP8—atopic dermatitis	4.26e-05	0.00061	CbGpPWpGaD
Boceprevir—Dry mouth—Triamcinolone—atopic dermatitis	4.24e-05	0.00035	CcSEcCtD
Boceprevir—Angioedema—Betamethasone—atopic dermatitis	4.22e-05	0.000349	CcSEcCtD
Boceprevir—Angioedema—Dexamethasone—atopic dermatitis	4.22e-05	0.000349	CcSEcCtD
Boceprevir—CTSS—Immune System—IL18—atopic dermatitis	4.22e-05	0.000604	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK8—atopic dermatitis	4.21e-05	0.000603	CbGpPWpGaD
Boceprevir—Nausea—Tacrolimus—atopic dermatitis	4.2e-05	0.000347	CcSEcCtD
Boceprevir—Angiopathy—Prednisone—atopic dermatitis	4.19e-05	0.000346	CcSEcCtD
Boceprevir—Confusional state—Methylprednisolone—atopic dermatitis	4.18e-05	0.000345	CcSEcCtD
Boceprevir—Immune system disorder—Prednisone—atopic dermatitis	4.18e-05	0.000345	CcSEcCtD
Boceprevir—Malaise—Dexamethasone—atopic dermatitis	4.17e-05	0.000344	CcSEcCtD
Boceprevir—Malaise—Betamethasone—atopic dermatitis	4.17e-05	0.000344	CcSEcCtD
Boceprevir—CTSS—Immune System—CD8A—atopic dermatitis	4.16e-05	0.000595	CbGpPWpGaD
Boceprevir—Vertigo—Dexamethasone—atopic dermatitis	4.15e-05	0.000343	CcSEcCtD
Boceprevir—Vertigo—Betamethasone—atopic dermatitis	4.15e-05	0.000343	CcSEcCtD
Boceprevir—Syncope—Betamethasone—atopic dermatitis	4.14e-05	0.000342	CcSEcCtD
Boceprevir—Syncope—Dexamethasone—atopic dermatitis	4.14e-05	0.000342	CcSEcCtD
Boceprevir—Arrhythmia—Prednisone—atopic dermatitis	4.13e-05	0.000341	CcSEcCtD
Boceprevir—Infection—Triamcinolone—atopic dermatitis	4.13e-05	0.000341	CcSEcCtD
Boceprevir—Hypotension—Hydrocortisone—atopic dermatitis	4.13e-05	0.000341	CcSEcCtD
Boceprevir—Infection—Methylprednisolone—atopic dermatitis	4.12e-05	0.00034	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD4—atopic dermatitis	4.1e-05	0.000587	CbGpPWpGaD
Boceprevir—Shock—Triamcinolone—atopic dermatitis	4.09e-05	0.000338	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—atopic dermatitis	4.09e-05	0.000338	CcSEcCtD
Boceprevir—Alopecia—Prednisone—atopic dermatitis	4.09e-05	0.000337	CcSEcCtD
Boceprevir—Shock—Methylprednisolone—atopic dermatitis	4.08e-05	0.000337	CcSEcCtD
Boceprevir—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.07e-05	0.000336	CcSEcCtD
Boceprevir—Loss of consciousness—Betamethasone—atopic dermatitis	4.06e-05	0.000335	CcSEcCtD
Boceprevir—Loss of consciousness—Dexamethasone—atopic dermatitis	4.06e-05	0.000335	CcSEcCtD
Boceprevir—Paraesthesia—Prednisolone—atopic dermatitis	4.06e-05	0.000335	CcSEcCtD
Boceprevir—Tachycardia—Triamcinolone—atopic dermatitis	4.06e-05	0.000335	CcSEcCtD
Boceprevir—Mental disorder—Prednisone—atopic dermatitis	4.05e-05	0.000334	CcSEcCtD
Boceprevir—Tachycardia—Methylprednisolone—atopic dermatitis	4.05e-05	0.000334	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	4.04e-05	0.000578	CbGpPWpGaD
Boceprevir—Skin disorder—Methylprednisolone—atopic dermatitis	4.03e-05	0.000333	CcSEcCtD
Boceprevir—Erythema—Prednisone—atopic dermatitis	4.02e-05	0.000332	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—atopic dermatitis	4.02e-05	0.000332	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.02e-05	0.000332	CcSEcCtD
Boceprevir—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.02e-05	0.000332	CcSEcCtD
Boceprevir—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.01e-05	0.000331	CcSEcCtD
Boceprevir—Insomnia—Hydrocortisone—atopic dermatitis	3.99e-05	0.00033	CcSEcCtD
Boceprevir—Hypertension—Dexamethasone—atopic dermatitis	3.99e-05	0.000329	CcSEcCtD
Boceprevir—Hypertension—Betamethasone—atopic dermatitis	3.99e-05	0.000329	CcSEcCtD
Boceprevir—Paraesthesia—Hydrocortisone—atopic dermatitis	3.96e-05	0.000327	CcSEcCtD
Boceprevir—Myalgia—Dexamethasone—atopic dermatitis	3.93e-05	0.000325	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—atopic dermatitis	3.93e-05	0.000325	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD4—atopic dermatitis	3.93e-05	0.000563	CbGpPWpGaD
Boceprevir—Anxiety—Betamethasone—atopic dermatitis	3.92e-05	0.000324	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—atopic dermatitis	3.92e-05	0.000324	CcSEcCtD
Boceprevir—CTSK—Immune System—NFKBIA—atopic dermatitis	3.91e-05	0.00056	CbGpPWpGaD
Boceprevir—Discomfort—Dexamethasone—atopic dermatitis	3.89e-05	0.000321	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—atopic dermatitis	3.89e-05	0.000321	CcSEcCtD
Boceprevir—Dyspepsia—Hydrocortisone—atopic dermatitis	3.89e-05	0.000321	CcSEcCtD
Boceprevir—Hypotension—Methylprednisolone—atopic dermatitis	3.88e-05	0.00032	CcSEcCtD
Boceprevir—Pain—Prednisolone—atopic dermatitis	3.87e-05	0.000319	CcSEcCtD
Boceprevir—Decreased appetite—Hydrocortisone—atopic dermatitis	3.84e-05	0.000317	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.81e-05	0.000315	CcSEcCtD
Boceprevir—Fatigue—Hydrocortisone—atopic dermatitis	3.81e-05	0.000314	CcSEcCtD
Boceprevir—Vision blurred—Prednisone—atopic dermatitis	3.79e-05	0.000313	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.79e-05	0.000313	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.78e-05	0.000312	CcSEcCtD
Boceprevir—Pain—Hydrocortisone—atopic dermatitis	3.78e-05	0.000312	CcSEcCtD
Boceprevir—Insomnia—Triamcinolone—atopic dermatitis	3.76e-05	0.00031	CcSEcCtD
Boceprevir—Insomnia—Methylprednisolone—atopic dermatitis	3.75e-05	0.00031	CcSEcCtD
Boceprevir—Infection—Dexamethasone—atopic dermatitis	3.75e-05	0.000309	CcSEcCtD
Boceprevir—Infection—Betamethasone—atopic dermatitis	3.75e-05	0.000309	CcSEcCtD
Boceprevir—Ill-defined disorder—Prednisone—atopic dermatitis	3.73e-05	0.000308	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—atopic dermatitis	3.73e-05	0.000308	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—atopic dermatitis	3.73e-05	0.000308	CcSEcCtD
Boceprevir—Paraesthesia—Methylprednisolone—atopic dermatitis	3.72e-05	0.000308	CcSEcCtD
Boceprevir—Anaemia—Prednisone—atopic dermatitis	3.72e-05	0.000307	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCL5—atopic dermatitis	3.72e-05	0.000532	CbGpPWpGaD
Boceprevir—Shock—Betamethasone—atopic dermatitis	3.71e-05	0.000306	CcSEcCtD
Boceprevir—Shock—Dexamethasone—atopic dermatitis	3.71e-05	0.000306	CcSEcCtD
Boceprevir—Dyspnoea—Triamcinolone—atopic dermatitis	3.71e-05	0.000306	CcSEcCtD
Boceprevir—Nervous system disorder—Dexamethasone—atopic dermatitis	3.7e-05	0.000305	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—atopic dermatitis	3.7e-05	0.000305	CcSEcCtD
Boceprevir—Agitation—Prednisone—atopic dermatitis	3.7e-05	0.000305	CcSEcCtD
Boceprevir—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.69e-05	0.000305	CcSEcCtD
Boceprevir—Thrombocytopenia—Betamethasone—atopic dermatitis	3.69e-05	0.000305	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—atopic dermatitis	3.68e-05	0.000304	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—atopic dermatitis	3.68e-05	0.000304	CcSEcCtD
Boceprevir—Angioedema—Prednisone—atopic dermatitis	3.68e-05	0.000304	CcSEcCtD
Boceprevir—Dyspepsia—Triamcinolone—atopic dermatitis	3.66e-05	0.000302	CcSEcCtD
Boceprevir—Dyspepsia—Methylprednisolone—atopic dermatitis	3.65e-05	0.000301	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—atopic dermatitis	3.65e-05	0.000301	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.65e-05	0.000301	CcSEcCtD
Boceprevir—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.64e-05	0.0003	CcSEcCtD
Boceprevir—Malaise—Prednisone—atopic dermatitis	3.63e-05	0.0003	CcSEcCtD
Boceprevir—CTSL—Immune System—IFNG—atopic dermatitis	3.62e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—atopic dermatitis	3.62e-05	0.000518	CbGpPWpGaD
Boceprevir—Vertigo—Prednisone—atopic dermatitis	3.62e-05	0.000299	CcSEcCtD
Boceprevir—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.61e-05	0.000298	CcSEcCtD
Boceprevir—Syncope—Prednisone—atopic dermatitis	3.61e-05	0.000298	CcSEcCtD
Boceprevir—Urticaria—Prednisolone—atopic dermatitis	3.59e-05	0.000297	CcSEcCtD
Boceprevir—Fatigue—Triamcinolone—atopic dermatitis	3.58e-05	0.000296	CcSEcCtD
Boceprevir—Fatigue—Methylprednisolone—atopic dermatitis	3.58e-05	0.000295	CcSEcCtD
Boceprevir—Pain—Triamcinolone—atopic dermatitis	3.55e-05	0.000294	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—atopic dermatitis	3.54e-05	0.000292	CcSEcCtD
Boceprevir—CTSK—Immune System—CASP8—atopic dermatitis	3.53e-05	0.000505	CbGpPWpGaD
Boceprevir—Hypotension—Betamethasone—atopic dermatitis	3.52e-05	0.000291	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—atopic dermatitis	3.52e-05	0.000291	CcSEcCtD
Boceprevir—Urticaria—Hydrocortisone—atopic dermatitis	3.51e-05	0.00029	CcSEcCtD
Boceprevir—CTSL—Immune System—CD4—atopic dermatitis	3.5e-05	0.000501	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—atopic dermatitis	3.5e-05	0.000501	CbGpPWpGaD
Boceprevir—Abdominal pain—Hydrocortisone—atopic dermatitis	3.49e-05	0.000288	CcSEcCtD
Boceprevir—Body temperature increased—Hydrocortisone—atopic dermatitis	3.49e-05	0.000288	CcSEcCtD
Boceprevir—Hypertension—Prednisone—atopic dermatitis	3.47e-05	0.000287	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—MAPK8—atopic dermatitis	3.47e-05	0.000497	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGF—atopic dermatitis	3.44e-05	0.000493	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.44e-05	0.000284	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.44e-05	0.000284	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	3.43e-05	0.000491	CbGpPWpGaD
Boceprevir—Myalgia—Prednisone—atopic dermatitis	3.43e-05	0.000283	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—atopic dermatitis	3.43e-05	0.000283	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—atopic dermatitis	3.43e-05	0.000283	CcSEcCtD
Boceprevir—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.42e-05	0.000282	CcSEcCtD
Boceprevir—Anxiety—Prednisone—atopic dermatitis	3.41e-05	0.000282	CcSEcCtD
Boceprevir—Insomnia—Betamethasone—atopic dermatitis	3.41e-05	0.000282	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—atopic dermatitis	3.41e-05	0.000282	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.4e-05	0.000281	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.39e-05	0.00028	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—atopic dermatitis	3.39e-05	0.00028	CcSEcCtD
Boceprevir—Paraesthesia—Betamethasone—atopic dermatitis	3.39e-05	0.00028	CcSEcCtD
Boceprevir—Discomfort—Prednisone—atopic dermatitis	3.39e-05	0.00028	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR5—atopic dermatitis	3.35e-05	0.000479	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—atopic dermatitis	3.33e-05	0.000275	CcSEcCtD
Boceprevir—Dyspepsia—Betamethasone—atopic dermatitis	3.32e-05	0.000274	CcSEcCtD
Boceprevir—Dyspepsia—Dexamethasone—atopic dermatitis	3.32e-05	0.000274	CcSEcCtD
Boceprevir—Urticaria—Triamcinolone—atopic dermatitis	3.3e-05	0.000273	CcSEcCtD
Boceprevir—Urticaria—Methylprednisolone—atopic dermatitis	3.3e-05	0.000272	CcSEcCtD
Boceprevir—Body temperature increased—Triamcinolone—atopic dermatitis	3.29e-05	0.000271	CcSEcCtD
Boceprevir—Abdominal pain—Methylprednisolone—atopic dermatitis	3.28e-05	0.000271	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—atopic dermatitis	3.28e-05	0.000271	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—atopic dermatitis	3.28e-05	0.000271	CcSEcCtD
Boceprevir—Infection—Prednisone—atopic dermatitis	3.26e-05	0.000269	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.26e-05	0.000269	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.26e-05	0.000269	CcSEcCtD
Boceprevir—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.25e-05	0.000269	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—atopic dermatitis	3.25e-05	0.000269	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—atopic dermatitis	3.25e-05	0.000269	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—IL6—atopic dermatitis	3.25e-05	0.000465	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—atopic dermatitis	3.25e-05	0.000465	CbGpPWpGaD
Boceprevir—Shock—Prednisone—atopic dermatitis	3.23e-05	0.000267	CcSEcCtD
Boceprevir—CTSL—Immune System—IL1B—atopic dermatitis	3.23e-05	0.000462	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—atopic dermatitis	3.23e-05	0.000462	CbGpPWpGaD
Boceprevir—Pain—Dexamethasone—atopic dermatitis	3.23e-05	0.000266	CcSEcCtD
Boceprevir—Pain—Betamethasone—atopic dermatitis	3.23e-05	0.000266	CcSEcCtD
Boceprevir—CTSS—Immune System—NFKBIA—atopic dermatitis	3.22e-05	0.000461	CbGpPWpGaD
Boceprevir—Nervous system disorder—Prednisone—atopic dermatitis	3.22e-05	0.000266	CcSEcCtD
Boceprevir—CTSL—Immune System—IL2—atopic dermatitis	3.22e-05	0.000461	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—atopic dermatitis	3.22e-05	0.000461	CbGpPWpGaD
Boceprevir—Tachycardia—Prednisone—atopic dermatitis	3.21e-05	0.000265	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—atopic dermatitis	3.19e-05	0.000263	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	3.19e-05	0.000457	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Prednisone—atopic dermatitis	3.18e-05	0.000262	CcSEcCtD
Boceprevir—Asthenia—Hydrocortisone—atopic dermatitis	3.17e-05	0.000262	CcSEcCtD
Boceprevir—Pruritus—Hydrocortisone—atopic dermatitis	3.12e-05	0.000258	CcSEcCtD
Boceprevir—Feeling abnormal—Dexamethasone—atopic dermatitis	3.11e-05	0.000257	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—atopic dermatitis	3.11e-05	0.000257	CcSEcCtD
Boceprevir—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.08e-05	0.000255	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.08e-05	0.000255	CcSEcCtD
Boceprevir—Hypersensitivity—Triamcinolone—atopic dermatitis	3.06e-05	0.000253	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	3.06e-05	0.000438	CbGpPWpGaD
Boceprevir—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.06e-05	0.000252	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL2—atopic dermatitis	3.05e-05	0.000437	CbGpPWpGaD
Boceprevir—Diarrhoea—Hydrocortisone—atopic dermatitis	3.02e-05	0.000249	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.02e-05	0.000432	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IFNG—atopic dermatitis	3e-05	0.00043	CbGpPWpGaD
Boceprevir—Urticaria—Dexamethasone—atopic dermatitis	3e-05	0.000247	CcSEcCtD
Boceprevir—Urticaria—Betamethasone—atopic dermatitis	3e-05	0.000247	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.99e-05	0.000247	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—atopic dermatitis	2.99e-05	0.000247	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Asthenia—Methylprednisolone—atopic dermatitis	2.98e-05	0.000246	CcSEcCtD
Boceprevir—Insomnia—Prednisone—atopic dermatitis	2.97e-05	0.000245	CcSEcCtD
Boceprevir—CTSL—Immune System—MAPK8—atopic dermatitis	2.96e-05	0.000424	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK8—atopic dermatitis	2.96e-05	0.000424	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisone—atopic dermatitis	2.95e-05	0.000244	CcSEcCtD
Boceprevir—Pruritus—Triamcinolone—atopic dermatitis	2.94e-05	0.000243	CcSEcCtD
Boceprevir—Pruritus—Methylprednisolone—atopic dermatitis	2.93e-05	0.000242	CcSEcCtD
Boceprevir—Dizziness—Hydrocortisone—atopic dermatitis	2.92e-05	0.000241	CcSEcCtD
Boceprevir—CTSS—Immune System—CASP8—atopic dermatitis	2.91e-05	0.000416	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—atopic dermatitis	2.9e-05	0.000415	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—atopic dermatitis	2.89e-05	0.000239	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—atopic dermatitis	2.86e-05	0.000236	CcSEcCtD
Boceprevir—Rash—Prednisolone—atopic dermatitis	2.85e-05	0.000235	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—atopic dermatitis	2.85e-05	0.000235	CcSEcCtD
Boceprevir—Diarrhoea—Methylprednisolone—atopic dermatitis	2.84e-05	0.000234	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NFKBIA—atopic dermatitis	2.84e-05	0.000406	CbGpPWpGaD
Boceprevir—Fatigue—Prednisone—atopic dermatitis	2.83e-05	0.000234	CcSEcCtD
Boceprevir—Headache—Prednisolone—atopic dermatitis	2.83e-05	0.000234	CcSEcCtD
Boceprevir—Constipation—Prednisone—atopic dermatitis	2.81e-05	0.000232	CcSEcCtD
Boceprevir—Vomiting—Hydrocortisone—atopic dermatitis	2.81e-05	0.000232	CcSEcCtD
Boceprevir—Rash—Hydrocortisone—atopic dermatitis	2.78e-05	0.00023	CcSEcCtD
Boceprevir—Dermatitis—Hydrocortisone—atopic dermatitis	2.78e-05	0.00023	CcSEcCtD
Boceprevir—Headache—Hydrocortisone—atopic dermatitis	2.77e-05	0.000228	CcSEcCtD
Boceprevir—Dizziness—Triamcinolone—atopic dermatitis	2.75e-05	0.000227	CcSEcCtD
Boceprevir—Dizziness—Methylprednisolone—atopic dermatitis	2.74e-05	0.000226	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisone—atopic dermatitis	2.71e-05	0.000224	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—atopic dermatitis	2.71e-05	0.000223	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—atopic dermatitis	2.71e-05	0.000223	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IL6—atopic dermatitis	2.69e-05	0.000385	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Prednisone—atopic dermatitis	2.69e-05	0.000222	CcSEcCtD
Boceprevir—Nausea—Prednisolone—atopic dermatitis	2.69e-05	0.000222	CcSEcCtD
Boceprevir—CTSK—Immune System—IL1B—atopic dermatitis	2.68e-05	0.000383	CbGpPWpGaD
Boceprevir—Pruritus—Dexamethasone—atopic dermatitis	2.67e-05	0.00022	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—atopic dermatitis	2.67e-05	0.00022	CcSEcCtD
Boceprevir—CTSK—Immune System—IL2—atopic dermatitis	2.67e-05	0.000382	CbGpPWpGaD
Boceprevir—Vomiting—Triamcinolone—atopic dermatitis	2.64e-05	0.000218	CcSEcCtD
Boceprevir—Vomiting—Methylprednisolone—atopic dermatitis	2.64e-05	0.000218	CcSEcCtD
Boceprevir—Nausea—Hydrocortisone—atopic dermatitis	2.62e-05	0.000217	CcSEcCtD
Boceprevir—Rash—Triamcinolone—atopic dermatitis	2.62e-05	0.000216	CcSEcCtD
Boceprevir—Dermatitis—Triamcinolone—atopic dermatitis	2.62e-05	0.000216	CcSEcCtD
Boceprevir—Rash—Methylprednisolone—atopic dermatitis	2.62e-05	0.000216	CcSEcCtD
Boceprevir—Dermatitis—Methylprednisolone—atopic dermatitis	2.61e-05	0.000216	CcSEcCtD
Boceprevir—Urticaria—Prednisone—atopic dermatitis	2.61e-05	0.000215	CcSEcCtD
Boceprevir—Headache—Triamcinolone—atopic dermatitis	2.6e-05	0.000215	CcSEcCtD
Boceprevir—Headache—Methylprednisolone—atopic dermatitis	2.6e-05	0.000215	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—atopic dermatitis	2.6e-05	0.000214	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—atopic dermatitis	2.6e-05	0.000214	CcSEcCtD
Boceprevir—Diarrhoea—Betamethasone—atopic dermatitis	2.58e-05	0.000213	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—atopic dermatitis	2.58e-05	0.000213	CcSEcCtD
Boceprevir—Dizziness—Dexamethasone—atopic dermatitis	2.49e-05	0.000206	CcSEcCtD
Boceprevir—Dizziness—Betamethasone—atopic dermatitis	2.49e-05	0.000206	CcSEcCtD
Boceprevir—CTSS—Immune System—IFNG—atopic dermatitis	2.47e-05	0.000354	CbGpPWpGaD
Boceprevir—Nausea—Triamcinolone—atopic dermatitis	2.47e-05	0.000204	CcSEcCtD
Boceprevir—Nausea—Methylprednisolone—atopic dermatitis	2.46e-05	0.000203	CcSEcCtD
Boceprevir—CTSK—Immune System—MAPK8—atopic dermatitis	2.45e-05	0.000351	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—atopic dermatitis	2.42e-05	0.0002	CcSEcCtD
Boceprevir—Vomiting—Betamethasone—atopic dermatitis	2.4e-05	0.000198	CcSEcCtD
Boceprevir—Vomiting—Dexamethasone—atopic dermatitis	2.4e-05	0.000198	CcSEcCtD
Boceprevir—CTSS—Immune System—CD4—atopic dermatitis	2.39e-05	0.000342	CbGpPWpGaD
Boceprevir—Rash—Dexamethasone—atopic dermatitis	2.38e-05	0.000196	CcSEcCtD
Boceprevir—Rash—Betamethasone—atopic dermatitis	2.38e-05	0.000196	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—atopic dermatitis	2.38e-05	0.000196	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—atopic dermatitis	2.38e-05	0.000196	CcSEcCtD
Boceprevir—Headache—Dexamethasone—atopic dermatitis	2.36e-05	0.000195	CcSEcCtD
Boceprevir—Headache—Betamethasone—atopic dermatitis	2.36e-05	0.000195	CcSEcCtD
Boceprevir—Asthenia—Prednisone—atopic dermatitis	2.36e-05	0.000195	CcSEcCtD
Boceprevir—Pruritus—Prednisone—atopic dermatitis	2.32e-05	0.000192	CcSEcCtD
Boceprevir—Diarrhoea—Prednisone—atopic dermatitis	2.25e-05	0.000186	CcSEcCtD
Boceprevir—Nausea—Dexamethasone—atopic dermatitis	2.24e-05	0.000185	CcSEcCtD
Boceprevir—Nausea—Betamethasone—atopic dermatitis	2.24e-05	0.000185	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.22e-05	0.000318	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—atopic dermatitis	2.22e-05	0.000317	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.21e-05	0.000316	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—atopic dermatitis	2.2e-05	0.000316	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—atopic dermatitis	2.2e-05	0.000314	CbGpPWpGaD
Boceprevir—Dizziness—Prednisone—atopic dermatitis	2.17e-05	0.000179	CcSEcCtD
Boceprevir—Vomiting—Prednisone—atopic dermatitis	2.09e-05	0.000172	CcSEcCtD
Boceprevir—Rash—Prednisone—atopic dermatitis	2.07e-05	0.000171	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—atopic dermatitis	2.07e-05	0.000171	CcSEcCtD
Boceprevir—Headache—Prednisone—atopic dermatitis	2.06e-05	0.00017	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.05e-05	0.000293	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—atopic dermatitis	2.02e-05	0.00029	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK8—atopic dermatitis	2.02e-05	0.000289	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.99e-05	0.000285	CbGpPWpGaD
Boceprevir—Nausea—Prednisone—atopic dermatitis	1.95e-05	0.000161	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—IL2—atopic dermatitis	1.93e-05	0.000277	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.9e-05	0.000271	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—atopic dermatitis	1.89e-05	0.000271	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—atopic dermatitis	1.89e-05	0.000271	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.82e-05	0.00026	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK8—atopic dermatitis	1.78e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—atopic dermatitis	1.57e-05	0.000224	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLB1—atopic dermatitis	1.43e-05	0.000205	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.39e-05	0.000198	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADSL—atopic dermatitis	1.37e-05	0.000196	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—atopic dermatitis	1.29e-05	0.000185	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—atopic dermatitis	1.14e-05	0.000163	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.1e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.91e-06	0.000142	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.82e-06	0.000126	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.45e-06	0.000121	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARA—atopic dermatitis	6.15e-06	8.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARA—atopic dermatitis	4.64e-06	6.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.86e-06	4.1e-05	CbGpPWpGaD
